# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-02-03 | **更新时间**: 09:24 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- `[05:00]` **CREATE Medicines 利用体内 CAR-T 平台在非人类灵长类动物中展示完全 B 细胞消除和可重复给药**
  <br><small>🇬🇧 *CREATE Medicines Demonstrates Complete B Cell Depletion and Repeatable Dosing in Non-human Primates with In Vivo CAR-T Platform* [🔗Source](https://news.google.com/rss/articles/CBMikAJBVV95cUxQZWw2MlVOaUc1dlVQNmJvZzdwdlFYM0JITENuczhKellTTmFpVHYzWEZLaWk4MFZGcUUyTUZkY3VNR3V6OE5iYTlTV0Y3OWtqNXpFaGxsNkVBb1dtWFVoWjhCYmVaWUpfbEREVDNwMUJ0LVUxV1dvak9xNnlDN0FWYUloMHo3N1NxRjQ1UmIwTk1mSFBwS1Y2ZE9LVHNQQWxvV0FGMndJSnlmbFFub0ZyTlFMb0U2Mm1jaFJZWVV6Zkw2dER4bmRLci1Fd21weG5ndS1IbjN2bnNoN2daallLZFZkVEJaUVBpZy1tb1RuYkpOMHZyWFhFalJaVGVyT05XQVhCaGNOaXZ4TnZOQWVSUw?oc=5)</small>
- `[22:00]` **Anixa Biosciences 获得美国采用名称委员会批准其 CAR-T 疗法的非专有名称，这是未来商业化的关键一步**
  <br><small>🇬🇧 *Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization* [🔗Source](https://news.google.com/rss/articles/CBMiuwJBVV95cUxQVDJINHlreUlKdTY0Qndnb2t6TTRtWVY3ZklrREFiYTlNTldXTk9jNkdTdnk0Uy1RLW5zWmlUU2VfYTZ4MGo3eUY3NlJfVHRhbktVaFJsRXJ0WVFwQTZNeUsycHNvbllweXRfQjloWnlaWmRKc3FCa19MSFR2VFBxWEtDaFBuZjJiOFEta09rVWRjNkZDb2xrdzdscU5UXzZFYVl0SnR1czdiSU0xVVNEeDRjc3Bja0xXMy1Ia2NsbTZkOHBiWjNlSWx4czNiVVF3U2dEM29DdW5jNjRJSnRQM1YwbEdzaXB2eF9XTGN3bE9Hd19OQ1Y2R1N4N3JscF9RYTBQR3g2dnBVTU03eG14OUZlQ1lOQnA3a3RFUlhibkZmZDFSYUY2MmhKU08wTjNQSlIyMll1Z1Jmazg?oc=5)</small>
- `[20:00]` **ImmunityBio 推出 ANKTIVA® (ResQ215B) 治疗惰性淋巴瘤的 2 期免化疗 CAR-NK 细胞治疗试验**
  <br><small>🇬🇧 *ImmunityBio Launches Phase 2 Chemotherapy-Free CAR-NK Cell Therapy Trial with ANKTIVA® (ResQ215B) in Indolent Lymphomas* [🔗Source](https://news.google.com/rss/articles/CBMigwJBVV95cUxNb2Zqell6a3hiMTFHUUtWUFNudlpCdmQ4aDZaM3NVSXROQTNCWlNyaUE0ZnlYWjJFUVgydFE4QTVPbnZtTDBGOVV5Q0FaY2V3X1ZOWGxtOC1wemNjZ3MxcUQxX25HM1QtM0ZaaXNzM3Q5VzNEbGxpblhxVDBObmtwbnFFcy1SQ1BuZzRtdE5LZDJocXNhSlZSNU1nbmxhR1FVbVdYODZwY3Z4SW9KRTBVVXJRZnpvQkFIMklHR1ZiS0N1Vmx4XzRfWUtjSi1iVUFlY1JoOFdOV0tLOUVxSkVIN25BN01XcVRQQVVxTTBqNUpySzVQTFZ2R2tYdUJ4NHpEQUNn?oc=5)</small>

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[07:20]` **一周超 30 款创新药获 IND 新进展，揭秘研发风向标** [🔗阅读原文](https://news.google.com/rss/articles/CBMiiwFBVV95cUxOUlhGT0Z0Tnl3emdreHpPLWlqNkpFdUR0Um9UZzdZQWtBajIwYjc2b2tjMkNoSUs4bDNHcE4zZ1h5bndoR0ZGUmNoanRsdVJXZlZnVVBLcG9oSlloWjhYYmc0STI0M2t1UlVPZC1YY0dTTk1kX0NzY29uUmQ5S0VnOF9jS1JXZERtVnRn?oc=5)
- `[04:44]` **🏛️监管 | 北京上市中国首个获批干细胞疗法，售价仅为 2,850 美元**
  <br><small>🇬🇧 *Beijing Lists China's First Approved Stem Cell Therapy at Just $2,850* [🔗Source](https://news.google.com/rss/articles/CBMirwFBVV95cUxOZEhzTDdfaDVmNjlnWGhiMGMtQy0xa1FjMEFma2RrU19FMXhxNG5WY25XdmxlS0ZLQTVmc2lia1JzaEQ0LTRJUDY2ZFNuWWFjQTZUMUNpb3BWQXUzR3Z2cUxDUDhoWFhfSzk4TmhYVWFxTXdpaEUxb3JiSTdOQkt0QzFjTTl6elZ6c0hJRk1MMDF3QkxTX0xManBiQnJnT1U2a2FhUXFRaml5N3FLWmFZ?oc=5)</small>
- `[01:23]` **Anixa Biosciences 获得美国委员会批准新型 CAR-T 疗法名称**
  <br><small>🇬🇧 *Anixa Biosciences receives USAN Council approval for novel CAR-T therapy name* [🔗Source](https://news.google.com/rss/articles/CBMi1wFBVV95cUxNOE9uTUFpOV95VG51S0NsUXhNM0o0d2hCeXhjM2pfZGwtZUZZUjM3bmJoQVFuRFM5YVFZdEpNYTV2ekNJYVhZRTF0clljSTl3YVRRWW4wTnNTTWFiOE1kZ1RrVGpHME1xU1Z4dWNmM29vTmZ5YjE1UllQLXNrNERvaUNYcDc5cHduWjF4aE0tZ08xVnpUR1JfSXJUT0V1SnVzWS1mLXNqY0ZPZTh3NGJYcThjNk94Sk54cWNCNDExb1N4NE5rTTBLdTQ5d04tMnNlR3FwYnBMVQ?oc=5)</small>
- `[21:21]` **CAR-T细胞治疗新突破：改造CXCR4如何精准打击B细胞恶性肿瘤？** [🔗阅读原文](https://news.google.com/rss/articles/CBMiRkFVX3lxTFBucWhIOVRFMEtzdkpRWk9oaEdraV9EU2g5YkVrYVJsRzVrZkhBR0c2TDNqN2MyRUw0NWdEWlVZeVVEeDJ5dEE?oc=5)
- `[17:59]` **2025“爆发元年”：in-vivo CAR-T里程碑汇总！** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE1TSmxrdUZ3cjcyZF9mbTBYNlpWaFo0SnQ5a0hXRlJ2ajBONFpwYUhVT0NFbzhEakZ4REtjR1EwZFgydlB3Tjd3YTdia1dRYXBlVVhGcmg3TXdaZ00xMlVqU2UwaEI2SnFLc2ZoV1pjY1FaVWU4c3RnSjRVU1dVUQ?oc=5)
- `[16:13]` **政策法规：CDE发布《细胞治疗药品药学变更研究与评价技术指导原则（试行）》的通知** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE9xSG9BUEoyLU9sZ3VXd183M2FsZWdhSjFWelNhSmZKenV1ZmxqM0RWeTlBb1cwTmdwRlpzaHRiXzN2bzBfMDlnd0xmdzh3WVIzQTFUSXplci1fbGxwZm56Y0Z3N2xuNC1EcjRXa21mZi1udnFxVGFLQWRMbVB6dw?oc=5)
- `[16:05]` **CAR-T细胞疗法在自身免疫性疾病中的应用** [🔗阅读原文](https://news.google.com/rss/articles/CBMiVkFVX3lxTE50QXBwRXh5VFRPa0g0U2V0a19sZnZKeElvOUlhWng3a1ZTaFV2NmZrSFdqdk1FYVdNdVp2ZWpNdmlwa0RrY2U4WGxlOE5nMmJaOXBYRm9B?oc=5)
- `[13:18]` **临床试验日益走向全球——中国是主要受益者**
  <br><small>🇬🇧 *Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary* [🔗Source](https://news.google.com/rss/articles/CBMiuAFBVV95cUxPeEVjbzlWN2ZfQWk0cFNsUnRYZ0dIdzNPOGxaQnRUZzhQSFZsOTRYU0x2dUFFRkJBVDVuN29ZWHI4anYzeEc1VjExM3VUYzBIazktOEgtRGF4YVZ6RTFfNWhUcGtqek1LWlZub2h6Rk9ZMTJYQ0ZEN2Z2el9Ed0hsZzN2WG8xdGdGenpkSDBrZWxiOWRQRC1RY1I4cFZLd3VMYjFIVzVTYWI0UWVpOVRHb080YjBwc1dK?oc=5)</small>
- `[10:09]` **🏛️监管 | 石药集团创新突破：SYS6055注射液成国内首款体内CAR-T临床获批药，SYHX2011晚期乳腺癌疗效显著** [🔗阅读原文](https://news.google.com/rss/articles/CBMiWkFVX3lxTE4tOE8wbVduNHdpcDVZaDVwSlFLOGZBemtGd0M2T3hqMHVncHRCdDBqb1doMjRyZW92LUtLNEpaNFZHeUlia0Iwa3JvX2dZdTQ1TzMzSUVBNVRjQQ?oc=5)
